Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
SANUWAVE Health, Inc.
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
21 mars 2025 06h00 HE
|
SANUWAVE Health, Inc.
Sanuwave Health Inc reported fourth-quarter and full-year 2024 results and issued first-quarter and full-year 2025 guidance.
Sanuwave Health to Uplist to the Nasdaq Global Market
04 mars 2025 16h06 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products,...
SANUWAVE Health to Participate in 37th Annual Roth Conference
19 févr. 2025 09h04 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, Minn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that Morgan Frank,...
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results
08 nov. 2024 06h00 HE
|
SANUWAVE Health, Inc.
Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company. Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023 GAAP Operating Income was $2.0...
SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
04 nov. 2024 07h30 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, Minn., Nov. 04, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will...
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering
18 oct. 2024 09h00 HE
|
SANUWAVE Health, Inc.
1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion...
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
16 oct. 2024 07h30 HE
|
SANUWAVE Health, Inc.
Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024 EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB:...
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
13 août 2024 06h00 HE
|
SANUWAVE Health, Inc.
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income...
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
07 août 2024 18h51 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will...
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
10 avr. 2024 08h30 HE
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...